Purdue Pharma judge extends Sacklers’ litigation shield to Feb 17 -Breaking
[ad_1]
© Reuters. FILE PHOTO – OxyContin, a prescription painkiller, is displayed at a Provo, Utah pharmacy counter on April 25, 2017, by Purdue Pharma LP. REUTERS/George Frey(Reuters) – On Tuesday, a U.S. court extended a protective shield to the Purdue Pharma family owners from suitors up to February 17. They are trying to negotiate a settlement with multiple states in order to resolve sprawling lawsuits stemming out of the nation’s opioid crisis.
Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.
Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from relying on data including charts, buy/sell signals, and quotes. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.
[ad_2]